Stocks and InvestingStocks and Investing
Mon, July 17, 2023
Fri, July 14, 2023
Thu, July 13, 2023

Tazeen Ahmad Upgraded (BCRX) to Strong Buy and Held Target at $10 on, Jul 13th, 2023


Published on 2024-10-28 04:48:46 - WOPRAI, Tazeen Ahmad
  Print publication without navigation


Tazeen Ahmad of B of A Securities, Upgraded "BioCryst Pharmaceuticals, Inc." (BCRX) to Strong Buy and Held Target at $10 on, Jul 13th, 2023.

Tazeen has made no other calls on BCRX in the last 4 months.



There are 3 other peers that have a rating on BCRX. Out of the 3 peers that are also analyzing BCRX, 1 agrees with Tazeen's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Brian Abrahams of "RBC Capital" Reiterated at Hold and Held Target at $9 on, Thursday, May 4th, 2023


These are the ratings of the 2 analyists that currently disagree with Tazeen


  • Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $14 on, Thursday, May 4th, 2023
  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Decreased Target to $10 on, Thursday, April 20th, 2023